Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alexandra Nanzer-Kelly"'
Autor:
Grainne D'Ancona, H. Dhruve, Alexandra Nanzer-Kelly, Jaideep Dhariwal, David A. Jackson, S. Holmes
Publikováno v:
Treatment and adherence in asthma.
Introduction and ObjectiveThe COVID-19 pandemic has witnessed a reduction in asthma exacerbations in the UK. Several factors may underpin this, including reduced transmission of seasonal viruses and improved use of or adherence to inhaled corticoster
Autor:
Liang-Wen Hang, Karrinda Kenny, Louis-Philippe Boulet, Jane Duke, Désirée Larenas-Linnemann, Claude S. Farah, Mónica De Gennaro, Peter A. B. Wark, Hubertus Jersmann, Maria Teresa Costantino, Dermot Ryan, Mark Hew, Vanessa M. McDonald, Mohammad Hashim Khan, Pin-Kuei Fu, Mitesh Patel, Majdy Idrees, David A. Jackson, Violina Vasileva, Constance H. Katelaris, Matthew Masoli, Nunzio Crimi, Celeste Porsbjerg, Janet Rimmer, Veronica Lawriwskyj, Ying-Chun Chien, Norma Linaker, Sally E. Wenzel, Alan Altraja, Ricardo Campos, Carlos Torres-Duque, Manlio Milanese, Enrico Heffler, Eleftherios Zervas, Andréanne Côté, Guy Brusselle, Alan James, Luis Perez-de-Llano, Jorge Maspero, David Langton, Francesca Puggioni, Mona Al-Ahmad, Riyard Al-Lehebi, Adel H. Mansur, Tom Brown, José Luis Miguel, Chris Corrigan, Arnaud Bourdin, James Fingleton, Brian J. Lipworth, Shrikant Pawar, Paula Kauppi, Philip G. Bardin, Alexandra Nanzer-Kelly, Carlos Andrés Celis-Preciado, Santus Pierachille, David Price, George Christoff, Pauline Hughes, Hitashi Rupani, João Fonseca, Nikolaos G. Papadopoulos, Naghmeh Radhakrishna, Lauri Lehtimäki, Rekha Chaudhuri, Anne-Maree Cheffins, Tara Mackenzie, Christian Taube, Kenneth R. Chapman, Charlotte Suppli Ulrik, Giorgio Walter Canonica, Mariko Koh Siyue, Maria Elisabetta Conte, Giovanna Elisiana Carpagnano, Chantal E. Le Lievre, Mohsen Sadatsafavi, Unnur S. Bjornsdottir, Praveen Akuthota, Mark FitzGerald, Andrew Menzies-Gow, Jaideep Dhariwal, Stelios Loukides, Michael E. Wechsler, Paul E Pfeffer, Matthew J. Peters, Giuseppe Guida, Zinta Harrington, Konstantinos Kostikas, Ian Clifton, Tze Lee Tan, Andriana I. Papaioannou, Li Ping Chung, John W. Upham, Parameswaran Nair, John Harrington, Aikaterini Detoraki, Liam G Heaney, Roberta Parente, Paul M. O'Byrne, Jo A Douglass, Kanok Pipatvech, Ming-Ju Tsai, Caterina Bucca, Vibeke Backer, Peter Middleton, Patrick Mitchell, Paddy Dennison, Luisa Ricciardi, Njira L Lugogo, Job F M van Boven, Flavia C.L. Hoyte, Stephen J. Fowler, Gregory Katsoulotos, Bassam Mahboub, Rovira Francisco, Nicola A. Hanania, John Corless, Mona-Rita Yacoub
Publikováno v:
Journal of Allergy and Clinical Immunology: In Practice
Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2021, ⟨10.1016/j.jaip.2021.06.041⟩
Journal of Allergy and Clinical Immunology: In Practice, Elsevier, 2021, ⟨10.1016/j.jaip.2021.06.041⟩
Background Clinicians are increasingly recognizing severe asthma patients in whom biologics and other add-on therapies lead to dramatic improvement. Currently, there is no agreed-upon super-responder (SR) definition. Objective To survey severe asthma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::416ea553f71f14875689db0b55d8b3d5
https://hal.archives-ouvertes.fr/hal-03314809
https://hal.archives-ouvertes.fr/hal-03314809
Publikováno v:
Diagnostic and management challenges within asthma services.
Background Poor adherence to inhaled corticosteroids (ICS) is a frequent cause of poor asthma control and repeated exacerbations. However, little is known about whether any differences in adherence levels exist between ethnic groups, age group or tre
Autor:
M Fernandes, Joanne Kavanagh, Brian D. Kent, Cris Roxas, David C. Jackson, Victoria Payne, Linda K. Green, Grainne D'Ancona, Andrew P. Hearn, Jaideep Dhariwal, L Thomson, Alexandra Nanzer-Kelly
Publikováno v:
Airway pharmacology and treatment.
Introduction: Multiple biologic therapies targeting IgE, IL-4R, IL-5 and IL-5R are licensed for severe asthma. In all cases elevated blood eosinophil count is associated with improved clinical response. An elevated FeNO has also been shown to be a bi
Asthma is a chronic inflammatory disease of the bronchial airways that is characterized pathologically by a desquamative eosinophilic bronchitis and clinically by reversible airway narrowing and increased airway responsiveness to non-specific provoca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c27795f53da1b68cc74a477944904094
https://doi.org/10.1093/med/9780198746690.003.0410
https://doi.org/10.1093/med/9780198746690.003.0410
Autor:
Delphi panel: Adel Mansur, Aikaterini, Detoraki, Alan, Altraja, Alan, James, Alexandra, Nanzer-Kelly, Andréanne, Côté, Andrew, Menzies-Gow, Andriana, Papaioannou, Anne-Maree, Cheffins, Arnaud, Bourdin, Bassam, Mahboub, Brian, Lipworth, Carlos Andrés Celis-Preciado, Carlos, Torres-Duque, Caterina, Bucca, Celeste, Porsbjerg, Charlotte, Ulrik, Chris, Corrigan, Christian, Taube, Claude, Farah, Constance, Katelaris, David, Langton, Dermot, Ryan, Désirée, Larenas-Linnemann, Eleftherios, Zervas, Enrico, Heffler, Flavia, Hoyte, Francesca, Puggioni, George, Christoff, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Giuseppe, Guida, Gregory, Katsoulotos, Guy, Brusselle, Hitashi, Rupani, Hubertus, Jersmann, Ian, Clifton, Jaideep, Dhariwal, James, Fingleton, Jane, Duke, Janet, Rimmer, Douglass, Jo, João, Fonseca, Job van Boven, John, Corless, John, Harrington, Jorge, Maspero, José Luis Miguel, Kanok, Pipatvech, Karrinda, Kenny, Kenneth, Chapman, Konstantinos, Kostikas, Lauri, Lehtimäki, Li Ping Chung, Liam, Heaney, Liang-Wen, Hang, Louis-Philippe, Boulet, Luis, Perez-de-Llano, Ricciardi, Luisa, Majdy, Idrees, Manlio, Milanese, Maria Elisabetta Conte, Maria Teresa Costantino, Mariko Koh Siyue, Mark, Fitzgerald, Mark, Hew, Matthew, Peters, Ming-Ju, Tsai, Mitesh, Patel, Mohammad Hashim Khan, Mohsen, Sadatsafavi, Mona, Al-Ahmad, Mona-Rita, Yacoub, Mónica De Gennaro, Naghmeh, Radhakrishna, Nicola Alexander Hanania, Nikolaos, Papadopoulos, Njira, Lugogo, Norma, Linaker, Nunzio, Crimi, Paddy, Dennison, Parameswaran, Nair, Patrick David Mitchell, Paul, O’Byrne, Paul, Pfeffer, Paula, Kauppi, Pauline, Hughes, Peter, Middleton, Peter, Wark, Philip, Bardin, Pin-Kuei, Fu, Praveen, Akuthota, Rekha, Chaudhuri, Ricardo, Campos, Riyard, Al-Lehebi, Roberta, Parente, Rovira, Francisco, Sally, Wenzel, Santus, Pierachille, Shrikant, Pawar, Stelios, Loukides, Stephen, Fowler, Tara, Mackenzie, Thomas, Brown, Tze Lee Tan, Unnur, Björnsdóttir, Vanessa, Mcdonald, Veronica, Lawriwskyj, Vibeke, Backer, Violina, Vasileva, Ying-Chun, Chien, Zinta, Harrington.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3978::862f92b5c0a5653b8d9b0dfb69381950
http://hdl.handle.net/11570/3175853
http://hdl.handle.net/11570/3175853
Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma?
Autor:
Cris Roxas, Kirsten Stewart-Knight, Mariana Fernandes, Joanna Kavanagh, DJ Jackson, Leyla Osman, Grainne D'Ancona, L. Green, Brian D. Kent, Alexandra Nanzer-Kelly
Publikováno v:
Airway pharmacology and treatment.
Mepolizumab reduces maintenance oral corticosteroid (mOCS) requirement and exacerbation frequency, while improving symptom control in patients with severe eosinophilic asthma. The impact of any changes in maintenance inhaler use in patients receiving
Autor:
Mariana Fernandes, Cris Roxas, Brian D. Kent, Louise Thompson, Joanne Kavanagh, L. Green, Grainne D'Ancona, Alexandra Nanzer-Kelly, David A. Jackson
Publikováno v:
Airway pharmacology and treatment.
Introduction: Benralizumab is a monoclonal antibody against IL-5R and is licensed for the treatment of severe eosinophilic asthma (SEA). The phase 3 ZONDA study reported significant oral glucocorticoid (OCS) sparing efficacy with benralizumab. Howeve
Autor:
Brian D. Kent, Mariana Fernandes, Cris Roxas, Louise Thompson, Joanne Kavanagh, David A. Jackson, Alexandra Nanzer-Kelly, Grainne D'Ancona, L. Green
Publikováno v:
Airway pharmacology and treatment.
Introduction: Benralizumab is a monoclonal antibody against IL-5R and is licensed for the treatment of severe eosinophilic asthma (SEA). It is appreciated that there are sub-phenotypes of SEA relating to both atopy and age of onset. However, whether
Autor:
David C. Jackson, Cris Roxas, L. Green, Joanna Kavanagh, Mariana Fernandes, Grainne D'Ancona, Brian D. Kent, Sangita Agarwal, Alexandra Nanzer-Kelly
Publikováno v:
Airway pharmacology and treatment.
Eosinophilic granulomatosis with polyangiitis (EGPA) is an uncommon but potentially devastating disorder characterised by perivascular eosinophilic inflammation, severe asthma, peripheral eosinophilia, and sino-nasal disease, which is frequently comp